V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211392 | 20078584 | 1.66 | 80 | Palliative (P) | 2017-03-19 | 2017-03-22 | Capecitabine (14 days)+Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100972523 |
| 20211398 | 20078585 | 0 | 0 | Palliative (P) | 2019-07-19 | 2019-08-13 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101683580 |
| 20211406 | 20078586 | 1.63 | 49.6 | null | 2018-01-12 | 2018-01-25 | CAPECITABINE + CARBOPLATIN | 02 | null | TRIAL UNSPECIFIED | 100174025 |
| 20211411 | 20078587 | 0 | 0 | Palliative (P) | null | 2018-12-09 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100309107 |
| 20211422 | 20078588 | null | null | null | 2018-11-30 | 2018-12-14 | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 100999363 |
| 20211423 | 20078589 | 1.77 | 52.4 | Curative (C) | 2019-10-09 | 2019-10-17 | CAPECITABINE + CARBOPLATIN | 02 | null | TRIAL UNSPECIFIED | 100295729 |
| 20211426 | 20078590 | 1.67 | 119 | null | 2020-01-09 | 2020-01-29 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101605017 |
| 20211429 | 20078591 | 0 | 0 | Palliative (P) | 2018-10-25 | 2018-11-17 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100846687 |
| 20211431 | 20078592 | null | null | Palliative (P) | 2017-11-15 | 2017-11-29 | CAPECITABINE + CARBOPLATIN | N | N | DOXORUBICIN EMBOLISATION | 101378731 |
| 20211437 | 20078593 | null | null | Palliative (P) | 2019-11-29 | 2019-12-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101653384 |
| 20211442 | 20078594 | 0 | 0 | null | 2016-05-23 | 2016-06-15 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101123587 |
| 20211447 | 20078595 | 1.66 | 70.9 | Palliative (P) | 2018-05-13 | 2018-05-31 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101795480 |
| 20211451 | 20078596 | 1.7 | 51.3 | Palliative (P) | 2017-03-31 | 2017-04-28 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101858616 |
| 20211452 | 20078597 | 1.84 | 77.65 | Curative (C) | 2018-03-03 | 2018-03-03 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100135415 |
| 20211456 | 20078598 | null | null | Palliative (P) | null | 2017-08-03 | Capecitabine + Carboplatin + RT | 02 | N | DOXORUBICIN EMBOLISATION | 101755339 |
| 20211462 | 20078599 | 1.69 | 68.1 | Palliative (P) | 2017-06-09 | 2017-06-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101862304 |
| 20211464 | 20078600 | 1.62 | 80.5 | Palliative (P) | 2018-05-18 | 2018-05-21 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 100159355 |
| 20211465 | 20078601 | 1.58 | 67.6 | Neo-adjuvant (N) | 2019-06-05 | 2019-06-06 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101491430 |
| 20211471 | 20078602 | 1.73 | 95.4 | null | 2017-02-05 | 2017-02-10 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100468280 |
| 20211472 | 20078603 | 1.57 | 62.55 | Neo-adjuvant (N) | 2016-06-05 | 2016-06-22 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101760521 |
| 20211477 | 20078604 | 1.7 | 51.5 | 03 | 2019-05-30 | 2019-06-19 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100450674 |
| 20211483 | 20078605 | 1.63 | 66.5 | null | 2018-10-26 | 2018-11-13 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101281410 |
| 20211484 | 20078606 | 1.73 | 73 | null | 2019-08-15 | 2019-08-25 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101839380 |
| 20211488 | 20078607 | 1.65 | 83.6 | Palliative (P) | 2018-12-31 | 2019-01-20 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101119237 |
| 20211490 | 20078608 | 1.68 | 83.9 | null | 2017-09-04 | 2017-09-11 | Capecitabine (21days) + Carboplatin | 02 | null | CISPLATIN + FLUOROURACIL | 100866943 |
| 20211496 | 20078609 | 1.49 | 108 | Palliative (P) | 2018-01-23 | 2018-01-29 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 100520836 |
| 20211498 | 20078610 | 1.65 | 54.75 | Palliative (P) | 2016-05-10 | 2016-06-01 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100301450 |
| 20211504 | 20078611 | null | null | Palliative (P) | 2018-12-15 | 2018-12-15 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100255711 |
| 20211510 | 20078612 | 1.81 | 100 | Neo-adjuvant (N) | 2018-05-02 | 2018-05-05 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101165116 |
| 20211515 | 20078613 | null | 73.1 | Palliative (P) | 2019-02-22 | 2019-03-02 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100013977 |
| 20211516 | 20078614 | 1.55 | 45.8 | null | 2018-12-09 | 2018-12-22 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100942678 |
| 20211525 | 20078615 | 1.71 | 52.7 | Curative (C) | 2019-10-30 | 2019-10-31 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101178450 |
| 20211527 | 20078616 | 1.66 | 79.6 | Palliative (P) | 2018-02-04 | 2018-02-04 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 100857912 |
| 20211530 | 20078617 | 0 | 0 | Curative (C) | 2018-07-25 | 2018-08-16 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101564683 |
| 20211532 | 20078618 | 1.58 | 83 | Palliative (P) | 2017-06-11 | 2017-06-11 | CAPECITABINE + CARBOPLATIN | 2 | N | TRIAL UNSPECIFIED | 100187634 |
| 20211537 | 20078619 | 1.79 | 118 | Curative (C) | 2019-05-12 | 2019-05-30 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101097138 |
| 20211552 | 20078620 | 0 | 0 | Palliative (P) | 2017-03-11 | 2017-03-22 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100342809 |
| 20211556 | 20078621 | 0 | 0 | Curative (C) | 2017-06-07 | 2017-06-11 | Capecitabine (21days) + Carboplatin | 02 | Y | DOXORUBICIN EMBOLISATION | 100087176 |
| 20211560 | 20078622 | 1.73 | 68.3 | Palliative (P) | 2019-04-11 | 2019-04-25 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101062134 |
| 20211567 | 20078623 | null | 74 | Neo-adjuvant (N) | 2017-12-23 | 2017-12-30 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100375005 |
| 20211568 | 20078624 | 1.74 | 68.9 | Curative (C) | 2020-03-03 | 2020-03-17 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100686963 |
| 20211570 | 20078625 | 1.74 | 49 | Palliative (P) | 2017-12-21 | 2018-01-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100878858 |
| 20211571 | 20078626 | 1.77 | 51.7 | Palliative (P) | 2016-10-28 | 2016-11-25 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101839357 |
| 20211573 | 20078627 | 1.77 | 65.2 | Neo-adjuvant (N) | 2018-08-17 | 2018-08-31 | CAPECITABINE + CARBOPLATIN | 2 | N | CISPLATIN + FLUOROURACIL | 100614483 |
| 20211583 | 20078628 | 1.62 | 65.4 | Curative (C) | 2018-01-01 | 2018-01-22 | CAPECITABINE + CARBOPLATIN | N | Y | DOXORUBICIN EMBOLISATION | 101045102 |
| 20211588 | 20078629 | 1.69 | 85 | Palliative (P) | 2017-09-28 | 2017-10-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101367744 |
| 20211594 | 20078630 | 0 | 0 | Palliative (P) | 2018-04-26 | 2018-05-04 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 100745505 |
| 20211598 | 20078631 | 1.65 | 55.85 | Palliative (P) | 2017-04-23 | 2017-04-23 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101211617 |
| 20211601 | 20078632 | 1.65 | 88.6 | Neo-adjuvant (N) | 2019-10-18 | 2019-10-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100041671 |
| 20211605 | 20078633 | 1.73 | 97.8 | Neo-adjuvant (N) | 2016-10-27 | 2016-11-05 | Cisplatin +Fluorouracil (2 wk) | N | N | CISPLATIN + FLUOROURACIL | 100103960 |